Vietnam to produce Molnupiravir Covid-19 treatment
Trang Linh
The Medicines Patent Pool (MPP) has announced it has signed contracts with 27 medicine manufacturers in eleven countries, now including Vietnam, to produce the Molnupiravir Covid-19 treatment. The UK, the EU, the US, Japan, and many other countries have recently licensed the use of the medicine.